He et al. demonstrated that PI3K/Akt knockdown or pharmacological inhibition reduced the putative CSC population, whereas PI3K/Akt overactivation (via PTEN inhibition) led to CSC expansion in MCF-7 breast cancer and J82 bladder cancer cell lines [65]. The gene discussed is PTEN; the disease is urinary bladder cancer.